Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis

NCT00286351 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT00286351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00286351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis
Lead sponsor
Rigshospitalet, Denmark
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2005
Completion date
Not reported
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis